David Wilkes
Director/Board Member chez BAXTER INTERNATIONAL INC.
Fortune : 695 551 $ au 31/03/2024
Profil
David S.
Wilkes is the founder of ImmuneWorks, Inc. which was founded in 2006, where he holds the title of Chief Scientific Officer.
Currently, he is an Independent Director at Baxter International, Inc. and a Trustee at Villanova University.
In the past, he served as the National Director-Development Program at The Robert Wood Johnson Foundation, and as an Independent Director at Syneos Health, Inc. from 2021 to 2023.
He also served as the Dean-Emeritus at The University of Virginia School of Medicine from 2015 to 2021, and as the Dean at The Indiana University School of Medicine from 2009 to 2015.
Dr. Wilkes holds a doctorate degree from Temple University (Pennsylvania) and an undergraduate degree from Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/05/2024 | 16 274 ( 0,00% ) | 695 551 $ | 31/03/2024 |
Postes actifs de David Wilkes
| Sociétés | Poste | Début |
|---|---|---|
| BAXTER INTERNATIONAL INC. | Director/Board Member | 15/02/2021 |
ImmuneWorks, Inc.
 ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Founder | 01/01/2006 |
| Villanova University | Director/Board Member | - |
Anciens postes connus de David Wilkes
| Sociétés | Poste | Fin |
|---|---|---|
| SYNEOS HEALTH, INC. | Director/Board Member | 28/09/2023 |
| The University of Virginia School of Medicine | Corporate Officer/Principal | 01/01/2021 |
| The Indiana University School of Medicine | Corporate Officer/Principal | 01/01/2015 |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Corporate Officer/Principal | - |
Formation de David Wilkes
| Temple University (Pennsylvania) | Doctorate Degree |
| Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
The Robert Wood Johnson Foundation
The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Miscellaneous |
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Health Technology |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
